Anticancer nanomedicines have been proven effective in mitigating the side effects of
chemotherapeutic drugs. However, challenges remain in augmenting their therapeutic …

Every year, cancer is responsible for millions of deaths worldwide and, even though much
progress has been achieved in medicine, there are still many issues that must be addressed …

Biomedical polymers have been extensively developed for promising applications in a lot of
biomedical fields, such as therapeutic medicine delivery, disease detection and diagnosis …

Subcellular organelle‐targeted nanoformulations for cancer theranostics are receiving
increasing attention owing to their benefits of precise drug delivery, maximized therapeutic …

Polymeric micelles are demonstrating high potential as nanomedicines capable of
controlling the distribution and function of loaded bioactive agents in the body, effectively …

Gene therapy provides a promising approach in treating cancers with high efficacy and
selectivity and few adverse effects. Currently, the development of functional vectors with …

Biofilm has resulted in numerous obstinate clinical infections, posing severe threats to public
health. It is urgent to develop original antibacterial strategies for eradicating biofilms. Herein …

Planar donor and acceptor (D–A) conjugated structures are generally believed to be the
standard for architecting highly efficient photothermal theranostic agents, in order to restrict …

Nanomedicine has emerged as a promising mean to improve theranostic efficacy and
reduce side effects. Currently, only very small percentage of injected dose reaches the solid …

Current cancer nanomedicines can only mitigate adverse effects but fail to enhance
therapeutic efficacies of anticancer drugs. Rational design of next‐generation cancer …